Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma, Proc Natl Acad Sci, vol.83, pp.5214-5222, 1986. ,
The Bcl-2 protein family: arbiters of cell survival, Science, vol.281, pp.1322-1328, 1998. ,
Bcl2 family proteins in carcinogenesis and the treatment of cancer, Apoptosis, vol.14, pp.584-96, 2009. ,
Bcl-2 and the regulation of programmed cell death, J Cell Biol, vol.124, pp.1-6, 1994. ,
Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer, BMC Cancer, vol.8, p.153, 2008. ,
Bcl-2 and apoptosis in lymph node positive breast carcinoma, Cancer, vol.82, pp.1296-302, 1998. ,
BCL2 as a subtype-specific prognostic marker for breast Cancer, J Breast Cancer, vol.19, pp.252-60, 2016. ,
Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer, Clin Cancer Res, vol.1, pp.189-98, 1995. ,
Prognostic influence of BCL2 expression in breast cancer, Int J Cancer, vol.131, pp.1109-1128, 2012. ,
The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients, J Natl Cancer Inst, vol.86, pp.499-504, 1994. ,
BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received, Br J Cancer, vol.103, pp.668-75, 2010. ,
Prognostic influence of BCL2 on molecular subtypes of breast Cancer, J Breast Cancer, vol.20, pp.54-64, 2017. ,
A prognostic index for operable, node-negative breast cancer, Br J Cancer, vol.90, pp.1933-1974, 2004. ,
c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patients, Int J Cancer, vol.84, pp.562-569, 1999. ,
BCL2 family in DNA damage and cell cycle control, Cell Death Differ, vol.13, pp.1351-1360, 2006. ,
A Ki67/BCL2 index based on immunohistochemistry is highly prognostic in ER-positive breast cancer, J Pathol, vol.226, pp.97-107, 2012. ,
Analysis of the potent prognostic factors in luminal-type breast cancer, J Breast Cancer, vol.15, pp.401-407, 2012. ,
Prognostic value of Bcl-2 in two independent populations of estrogen receptor positive breast cancer patients treated with adjuvant endocrine therapy, Acta Oncol, vol.51, pp.781-790, 2012. ,
Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer, Breast Cancer Res Treat, vol.150, pp.141-149, 2015. ,
Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings, Ann Oncol, vol.24, pp.2801-2808, 2013. ,
Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy, BMC Cancer, vol.15, p.698, 2015. ,
Feline mammary tumors, Vet Clin North Am Small Anim Pract, vol.15, pp.513-533, 1985. ,
Animal model of human disease: breast cancer, Am J Pathol, vol.98, pp.573-579, 1980. ,
Early detection, aggressive therapy optimizing the management of feline mammary masses, J Feline Med Surg, vol.12, pp.214-238, 2010. ,
Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas, J Comp Pathol, vol.119, pp.263-75, 1998. ,
Argyrophilic nucleolar organiser regions (AgNORs) count as indicator of post-surgical prognosis in feline mammary carcinomas, Res Vet Sci, vol.64, pp.97-100, 1998. ,
Ki67 index as indicator of the post-surgical prognosis in feline mammary carcinomas, Res Vet Sci, vol.65, pp.223-229, 1998. ,
Prognosis of malignant mammary tumor in 53 cats, J Vet Med Sci, vol.58, pp.723-729, 1996. ,
Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential, Vet Pathol, vol.42, pp.30-34, 2005. ,
Grade is an independent prognostic factor for feline mammary carcinomas: a clinicopathological and survival analysis, Vet J, vol.187, pp.65-71, 2011. ,
Topographic distribution of bcl-2 protein in feline tissues in health and neoplasia, Vet Pathol, vol.36, pp.565-73, 1999. ,
Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions, Breast Cancer, vol.16, pp.173-181, 2009. ,
P63 and cytokeratin8/18 expression in breast, atypical ductal hyperplasia, ductal carcinoma in situ and invasive duct carcinoma, J Egypt Natl Canc Inst, vol.19, pp.202-212, 2007. ,
Pathological prognostic factors in breast cancer: I. the value of histological grade in breast cancer: experience from a large study with long-term follow-up, Histopathology, vol.19, pp.403-413, 1991. ,
Prognostic value of histologic grading for feline mammary carcinoma: a retrospective survival analysis, Vet Pathol, vol.52, issue.2, pp.238-287, 2015. ,
Mammary tumors in the cat: size matters, so early intervention saves lives, J Feline Med Surg, vol.15, pp.391-400, 2013. ,
TNM classification of Tumours in domestic animals. Geneva: World Health Organization, 1980. ,
Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification, Virchows Arch, vol.453, pp.123-155, 2008. ,
Aglepristone decreases proliferation in progesterone receptorpositive canine mammary carcinomas, J Vet Intern Med, vol.25, pp.518-541, 2011. ,
DOI : 10.1111/j.1939-1676.2011.0723.x
Canine invasive mammary carcinomas as models of human breast cancer. Part 1: natural history and prognostic factors, Breast Cancer Res Treat, vol.167, pp.635-683, 2018. ,
DOI : 10.1007/s10549-017-4548-2
URL : https://hal.archives-ouvertes.fr/inserm-01629625
Which threshold for ER positivity? A retrospective study based on 9639 patients, Ann Oncol, vol.25, pp.1004-1015, 2014. ,
DOI : 10.1093/annonc/mdu053
URL : https://academic.oup.com/annonc/article-pdf/25/5/1004/16698055/mdu053.pdf
St Gallen molecular subtypes in feline mammary carcinoma and paired metastases-disease progression and clinical implications from a 3-year follow-up study, Tumour Biol, vol.37, pp.4053-64, 2016. ,
DOI : 10.1007/s13277-015-4251-z
Prognostic impact of Ki-67 labeling indices with 3 different cutoff values, histological grade, and nuclear grade in hormone-receptorpositive, HER2-negative, node-negative invasive breast cancers, Breast Cancer, vol.22, pp.141-52, 2015. ,
Ki-67 as a prognostic factor in feline mammary carcinoma: what is the optimal cutoff value?, Vet Pathol, vol.53, issue.1, pp.37-43, 2016. ,
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update, Arch Pathol Lab Med, vol.138, pp.241-56, 2014. ,
Molecular phenotype in mammary tumours of queens: correlation between primary tumour and lymph node metastasis, J Comp Pathol, vol.148, pp.206-219, 2013. ,
Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype, BMC Cancer, vol.13, p.403, 2013. ,
DOI : 10.1186/1471-2407-13-403
URL : https://bmccancer.biomedcentral.com/track/pdf/10.1186/1471-2407-13-403
Survival of patients with metastatic breast carcinoma, Cancer, vol.97, pp.545-53, 2003. ,
DOI : 10.1002/cncr.11083
URL : https://www.onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.11083
Prognostic value of bcl-2 expression in invasive breast cancer, Br J Cancer, vol.72, pp.354-60, 1995. ,
p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients, Clin Cancer Res, vol.6, pp.2751-2759, 2000. ,
p53 and c-erbB-2 but not bcl-2 are predictive of metastasis-free survival in breast cancer patients receiving post-mastectomy adjuvant radiotherapy in Taiwan, Jpn J Clin Oncol, vol.32, pp.332-341, 2002. ,
Prognostic value of bcl-2 expression among women with breast cancer in Libya, Tumour Biol, vol.34, pp.1569-78, 2013. ,
Impact of BCL2 and p53 on postmastectomy radiotherapy response in high-risk breast cancer. A subgroup analysis of DBCG82 b&c, Acta Oncol, vol.47, pp.608-625, 2008. ,
Bcl-2 expression and apoptosis in primary and metastatic breast carcinomas, Tumour Biol, vol.22, pp.137-182, 2001. ,
DOI : 10.1159/000050608
Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas, Clin Cancer Res, vol.3, pp.2329-2364, 1997. ,
Prognostic indicators for breast cancer patients with one to three regional lymph node metastases, with special reference to alterations in expression levels of bcl-2, p53 and c-erbB-2 proteins, Jpn J Clin Oncol, vol.27, pp.371-378, 1997. ,
Different prognostic factors correlate with Bcl-2 expression among triple negative and non-triple negative breast cancers, Asian Pac J Cancer Prev, vol.14, pp.1037-1078, 2013. ,
Different prognostic significance of Bcl-2 based on Cancer molecular subtype, J Breast Cancer, vol.14, issue.1, pp.10-16, 2011. ,
Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity, Am J Pathol, vol.145, pp.535-575, 1994. ,
BCL-2, topoisomerase II?, microvessel density and prognosis of early advanced breast cancer patients after adjuvant anthracycline-based chemotherapy, J Cancer Res Clin Oncol, vol.140, pp.2009-2028, 2014. ,
Bcl-2 protein expression and longterm survival in breast cancer, Am J Pathol, vol.145, pp.1191-1199, 1994. ,
Correlations of Bcl-2 expression with clinicopathological features in breast cancer, Yonsei Med J, vol.38, pp.206-217, 1997. ,
Expression of the apoptosis-related genes BCL-2 and BAD in human breast carcinoma and their associated relationship with chemosensitivity, J Exp Clin Cancer Res, vol.29, p.107, 2010. ,
Bcl-2 antigen expression in luminal a and triple-negative breast cancer, Med Oncol, vol.34, p.161, 2017. ,
Paradoxical regulation of Bcl-2 family proteins by 17beta-oestradiol in human breast cancer cells MCF-7, Br J Cancer, vol.81, pp.387-92, 1999. ,
Prognostic significance of immunohistochemically localized biomarkers in stage II and stage III breast cancer: a multivariate analysis, Ann Surg Oncol, vol.7, pp.305-316, 2000. ,
Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham prognostic index, Clin Cancer Res, vol.12, pp.2468-75, 2006. ,
p53 and clinical outcome in a series of 138 operable breast cancer patients, Anticancer Res, vol.19, pp.4555-63, 1999. ,
Proposal for a modified grading system based on mitotic index and Bcl2 provides objective determination of clinical outcome for patients with breast cancer, J Pathol, vol.222, pp.388-99, 2010. ,
Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors, Hum Pathol, vol.43, pp.23-30, 2012. ,
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies, J Clin Invest, vol.121, pp.2750-67, 2011. ,
Does triplenegative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers, Ann Oncol, vol.18, pp.1285-1291, 2007. ,
Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18), Nature, vol.349, pp.254-260, 1991. ,
Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance, Clin Cancer Res, vol.9, pp.1161-70, 2003. ,
Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737, Cancer Res, vol.68, pp.7985-94, 2008. ,
ABT-737 reverses the acquired radioresistance of breast cancer cells by targeting Bcl-2 and Bcl-xL, J Exp Clin Cancer Res, vol.31, p.102, 2012. ,
Paradoxical inhibition of solid tumor cell growth by bcl2, Cancer Res, vol.54, pp.3714-3721, 1994. ,
Decoding and unlocking the BCL-2 dependency of cancer cells, Nat Rev Cancer, vol.13, pp.455-65, 2013. ,